$OMER
OMEROS CORP

2020 Q1 Form 10-K Financial Statement

#000155837020001891 Filed on March 02, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2018 Q4 2018 Q3
Revenue $23.54M $22.02M $4.608M
YoY Change 8.07% 60.01% -78.72%
Cost Of Revenue $267.0K $160.0K $36.00K
YoY Change 103.82% -65.96% -80.43%
Gross Profit $23.27M $21.86M $4.572M
YoY Change 7.49% 64.48% -78.71%
Gross Profit Margin 98.87% 99.29% 99.22%
Selling, General & Admin $18.04M $14.89M $13.15M
YoY Change 23.31% 23.77% 11.91%
% of Gross Profit 77.52% 68.12% 287.62%
Research & Development $28.91M $25.45M $26.86M
YoY Change 10.12% 65.37% 81.07%
% of Gross Profit 124.24% 116.42% 587.53%
Depreciation & Amortization $400.0K $310.0K $220.0K
YoY Change 5.26% 82.35% 46.67%
% of Gross Profit 1.72% 1.42% 4.81%
Operating Expenses $28.91M $40.49M $40.05M
YoY Change -29.52% 45.23% 49.62%
Operating Profit -$23.68M -$18.47M -$35.44M
YoY Change 23.07% 30.83% 593.58%
Interest Expense $5.903M -$5.150M $4.602M
YoY Change 5.41% 80.07% 65.54%
% of Operating Profit
Other Income/Expense, Net $549.0K $150.0K $572.0K
YoY Change 11.13% -65.12% 40.2%
Pretax Income -$29.03M -$36.46M -$39.47M
YoY Change 19.22% 120.3% 427.67%
Income Tax -$12.93M
% Of Pretax Income
Net Earnings -$29.03M -$23.53M -$39.47M
YoY Change 19.25% 42.19% 427.56%
Net Earnings / Revenue -123.34% -106.89% -856.6%
Basic Earnings Per Share
Diluted Earnings Per Share -$534.6K -$480.0K -$811.3K
COMMON SHARES
Basic Shares Outstanding 54.21M 49.01M shares 48.56M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2018 Q4 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $54.00M $60.50M $55.20M
YoY Change 14.41% -27.72% -36.41%
Cash & Equivalents $7.100M $5.900M $2.787M
Short-Term Investments $46.90M $54.60M $52.40M
Other Short-Term Assets $6.300M $6.500M $8.300M
YoY Change 50.0% -7.14% 45.61%
Inventory $1.211M $88.00K $214.0K
Prepaid Expenses $6.463M $8.334M
Receivables $24.00M $22.70M $2.200M
Other Receivables $106.0K $164.0K $132.0K
Total Short-Term Assets $85.61M $89.87M $66.00M
YoY Change 11.37% -17.08% -44.02%
LONG-TERM ASSETS
Property, Plant & Equipment $3.355M $3.845M $2.520M
YoY Change -25.09% 81.28% 41.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.200M $2.200M $7.100M
YoY Change -8.33% -62.07% 22.41%
Total Long-Term Assets $32.60M $6.069M $9.609M
YoY Change 33.76% -23.72% 26.1%
TOTAL ASSETS
Total Short-Term Assets $85.61M $89.87M $66.00M
Total Long-Term Assets $32.60M $6.069M $9.609M
Total Assets $118.2M $95.94M $75.61M
YoY Change 16.76% -17.53% -39.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.96M $6.281M $8.847M
YoY Change 82.0% -6.13% 140.41%
Accrued Expenses $41.38M $30.19M $15.18M
YoY Change 18.83% 57.83% -25.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.200M $889.0K $560.0K
YoY Change -53.14% 81.43% 52.17%
Total Short-Term Liabilities $57.94M $37.36M $24.59M
YoY Change 30.18% 42.0% -0.42%
LONG-TERM LIABILITIES
Long-Term Debt $162.0M $150.6M $131.7M
YoY Change 5.81% 79.04% 59.09%
Other Long-Term Liabilities $30.10M $8.200M $8.300M
YoY Change 21.86% -5.75% -5.68%
Total Long-Term Liabilities $192.1M $158.8M $131.7M
YoY Change 8.04% 88.78% 59.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $57.94M $37.36M $24.59M
Total Long-Term Liabilities $192.1M $158.8M $131.7M
Total Liabilities $250.1M $196.1M $156.3M
YoY Change 12.51% 77.59% 45.42%
SHAREHOLDERS EQUITY
Retained Earnings -$763.6M -$650.1M -$626.6M
YoY Change 13.22% 24.22% 23.63%
Common Stock $631.8M $550.0M $490.0K
YoY Change 128834.29% 114001.45% 2.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$131.9M -$100.2M -$89.00M
YoY Change
Total Liabilities & Shareholders Equity $118.2M $95.94M $75.61M
YoY Change 16.76% -17.53% -39.76%

Cashflow Statement

Concept 2020 Q1 2018 Q4 2018 Q3
OPERATING ACTIVITIES
Net Income -$29.03M -$23.53M -$39.47M
YoY Change 19.25% 42.19% 427.56%
Depreciation, Depletion And Amortization $400.0K $310.0K $220.0K
YoY Change 5.26% 82.35% 46.67%
Cash From Operating Activities -$9.141M -$24.66M -$36.87M
YoY Change -29.4% 491.37% 229.2%
INVESTING ACTIVITIES
Capital Expenditures $66.00K -$100.0K -$80.00K
YoY Change -63.74% 166.67%
Acquisitions
YoY Change
Other Investing Activities $10.84M -$2.270M $33.16M
YoY Change -5.49% -141.8% -155.72%
Cash From Investing Activities $10.78M -$2.360M $33.06M
YoY Change -4.53% -143.46% -155.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.399M 30.09M 3.710M
YoY Change -1743.15% 2610.81% -94.57%
NET CHANGE
Cash From Operating Activities -9.141M -24.66M -36.87M
Cash From Investing Activities 10.78M -2.360M 33.06M
Cash From Financing Activities 2.399M 30.09M 3.710M
Net Change In Cash 4.034M 3.070M -100.0K
YoY Change -323.24% 29.54% -95.76%
FREE CASH FLOW
Cash From Operating Activities -$9.141M -$24.66M -$36.87M
Capital Expenditures $66.00K -$100.0K -$80.00K
Free Cash Flow -$9.207M -$24.56M -$36.79M
YoY Change -29.88% 488.97% 229.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:PropertyPlantAndEquipmentNet
CY2019Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
omer:OperatingAndFinanceLeaseLiabilityCurrent
CY2019Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
omer:OperatingAndFinanceLeaseLiabilityCurrent
CY2019Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
omer:OperatingAndFinanceLeaseLiabilityNoncurrent
CY2019Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
omer:OperatingAndFinanceLeaseLiabilityNoncurrent
CY2019Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
omer:OperatingAndFinanceLeaseLiabilityCurrent omer:OperatingAndFinanceLeaseLiabilityNoncurrent
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49011684
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54200810
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001285819
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2018 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2019 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2017 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
us-gaap:ProductMember
CY2018 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
us-gaap:ProductMember
CY2019 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
us-gaap:ProductMember
CY2019Q4 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
omer:OperatingAndFinanceLeaseLiabilityCurrent omer:OperatingAndFinanceLeaseLiabilityNoncurrent
CY2019 omer Period Chargebacks Are Settled
PeriodChargebacksAreSettled
P28D
CY2018Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2018Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2018Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2018Q4 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2019Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2019Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2019Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2019Q4 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019 dei Entity File Number
EntityFileNumber
001-34475
CY2019 dei Entity Registrant Name
EntityRegistrantName
OMEROS CORPORATION
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WA
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-1663741
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
201 Elliott Avenue West
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98119
CY2019 dei City Area Code
CityAreaCode
206
CY2019 dei Local Phone Number
LocalPhoneNumber
676-5000
CY2019 dei Security12b Title
Security12bTitle
Common Stock
CY2019 dei Trading Symbol
TradingSymbol
OMER
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2019 dei Entity Small Business
EntitySmallBusiness
false
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019Q2 dei Entity Public Float
EntityPublicFloat
729297324
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54205177
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3084000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5861000
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
57704000
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
54637000
CY2019Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
35185000
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
22818000
CY2019Q4 us-gaap Inventory Net
InventoryNet
1147000
CY2018Q4 us-gaap Inventory Net
InventoryNet
88000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6625000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6463000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
103745000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
89867000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3829000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3845000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27082000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1154000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1154000
CY2019Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
1159000
CY2018Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
1070000
CY2019Q4 us-gaap Assets
Assets
136969000
CY2018Q4 us-gaap Assets
Assets
95936000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5328000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6281000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
46627000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30186000
CY2019Q4 omer Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
3504000
CY2018Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
889000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
55459000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
37356000
CY2019Q4 omer Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
32318000
CY2018Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
1578000
CY2019Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
158213000
CY2018Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
148981000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
8177000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
549479000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-734611000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54200810
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49011684
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
542000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
490000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
625048000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-650125000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-109021000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-100156000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
136969000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
95936000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
111805000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29868000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64826000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
865000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
512000
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1078000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
109696000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
89860000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55599000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64626000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51718000
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
52044000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
175187000
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
142090000
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
108721000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-63382000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-112222000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-43895000
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-12993000
CY2019 us-gaap Interest Expense
InterestExpense
22657000
CY2018 us-gaap Interest Expense
InterestExpense
16252000
CY2017 us-gaap Interest Expense
InterestExpense
11030000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1553000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1781000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1444000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-84486000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-139686000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-53481000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12929000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-84486000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-126757000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-53481000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-84486000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-126757000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-53481000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.71
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.61
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.17
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
49523444
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48582636
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
45539362
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-37447000
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
63657000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11769000
CY2017 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
12688000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-53481000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-2814000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6732000
CY2018 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1424000
CY2018 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
11713000
CY2018 omer Adjustments To Additional Paid In Capital Convertible Debt Premiums Paid
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtPremiumsPaid
33180000
CY2018 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
55655000
CY2018 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
-12929000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-126757000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-100156000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
54238000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7598000
CY2019 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
13785000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-84486000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-109021000
CY2019 us-gaap Profit Loss
ProfitLoss
-84486000
CY2018 us-gaap Profit Loss
ProfitLoss
-126757000
CY2017 us-gaap Profit Loss
ProfitLoss
-53481000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
13785000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
11713000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
12688000
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
9232000
CY2018 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5635000
CY2017 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4187000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1790000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
962000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
551000
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-12993000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-12929000
CY2018 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
354000
CY2019 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
12367000
CY2018 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
5674000
CY2017 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
5107000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1059000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-355000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-685000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
251000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
498000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5270000
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13283000
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10109000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9520000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60073000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-103737000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-36227000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
334000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
567000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
350000
CY2019 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
58217000
CY2018 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
68782000
CY2017 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
65326000
CY2019 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
55150000
CY2018 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
94500000
CY2017 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
28078000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3401000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
25151000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37598000
CY2018 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
210000000
CY2018 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
44550000
CY2019 omer Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
7598000
CY2018 omer Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
6732000
CY2017 omer Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
11769000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
54238000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
63657000
CY2018 omer Increase Decrease In Restricted Investments
IncreaseDecreaseInRestrictedInvestments
-4681000
CY2018 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
132077000
CY2018 omer Payments For Premium Paid For Capped Call Option
PaymentsForPremiumPaidForCappedCallOption
33180000
CY2018 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
11902000
CY2018 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6800000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1139000
CY2018 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
951000
CY2017 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
431000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
60697000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
81053000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
74995000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2777000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2467000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1170000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5861000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3394000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2224000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3084000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5861000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3394000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
13462000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
8896000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
6895000
CY2019 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1440000
CY2018 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
2118000
CY2017 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1141000
CY2018 omer Noncash Transaction Conversion Of Accrued Interest Into Notes Payable
NoncashTransactionConversionOfAccruedInterestIntoNotesPayable
3408000
CY2017 omer Noncash Transaction Conversion Of Accrued Interest Into Notes Payable
NoncashTransactionConversionOfAccruedInterestIntoNotesPayable
3315000
CY2018 omer Warrants Issued
WarrantsIssued
1424000
CY2019 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 10.8pt;">Organization</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system, and immune-related diseases, including cancers. Our first drug product, OMIDRIA, is marketed in the United States (U.S.) for use during cataract surgery or intraocular lens replacement.</p>
CY2019Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
60800000
CY2019Q4 omer Net Working Capital Adjustments
NetWorkingCapitalAdjustments
48300000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-63400000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-112200000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-43900000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60100000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-103700000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-36200000
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 10.8pt;">Use of Estimates</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:18pt;margin:0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Significant items subject to such estimates include revenue recognition, accruals for manufacturing of drug product, clinical drug supply and clinical trials, lease liabilities, and stock-based compensation expense. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances; however, actual results could differ from these estimates.</p>
CY2019 omer Maximum Period Product Allowed For Return
MaximumPeriodProductAllowedForReturn
P12M
CY2019 us-gaap Advertising Expense
AdvertisingExpense
8000000.0
CY2018 us-gaap Advertising Expense
AdvertisingExpense
2500000
CY2017 us-gaap Advertising Expense
AdvertisingExpense
300000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11451046
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10556253
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9757861
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
35074000
CY2018Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
22654000
CY2019Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
111000
CY2018Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
164000
CY2019Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
35185000
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
22818000
CY2019Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
1600000
CY2018Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
400000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3100000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5900000
CY2018 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0
CY2019 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
91000
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
83000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
338000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
718000
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5000
CY2019Q4 us-gaap Inventory Net
InventoryNet
1147000
CY2018Q4 us-gaap Inventory Net
InventoryNet
88000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9864000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8090000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6035000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4245000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3829000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3845000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1800000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1000000.0
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
600000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30772000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1546000
CY2019Q4 omer Lease Liability
LeaseLiability
35822000
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y9M18D
CY2019Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2019Q4 omer Accrued Contract Research Costs
AccruedContractResearchCosts
24107000
CY2018Q4 omer Accrued Contract Research Costs
AccruedContractResearchCosts
12012000
CY2019Q4 omer Accrued Sales Rebates Fees And Discounts Current
AccruedSalesRebatesFeesAndDiscountsCurrent
10870000
CY2018Q4 omer Accrued Sales Rebates Fees And Discounts Current
AccruedSalesRebatesFeesAndDiscountsCurrent
8075000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3610000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3669000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3546000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2714000
CY2019Q4 omer Accrued Clinical Trial Costs
AccruedClinicalTrialCosts
1982000
CY2018Q4 omer Accrued Clinical Trial Costs
AccruedClinicalTrialCosts
820000
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1640000
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1677000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
872000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1219000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
46627000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30186000
CY2019 omer Number Of Options To Extend Lease
NumberOfOptionsToExtendLease
2
CY2019 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
true
CY2019Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27082000
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
2973000
CY2019Q4 omer Lease Right Of Use Asset
LeaseRightOfUseAsset
30055000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2282000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1222000
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1285
CY2019Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.1217
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
4604000
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1340000
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
337000
CY2019 us-gaap Short Term Lease Cost
ShortTermLeaseCost
275000
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
2045000
CY2019 us-gaap Sublease Income
SubleaseIncome
913000
CY2019 us-gaap Lease Cost
LeaseCost
7688000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
6951000
CY2019 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
337000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1139000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6398000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1434000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6536000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1076000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6678000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
490000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
6823000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
131000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
6972000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
27000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
19590000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
52997000
CY2019Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
3158000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
19943000
CY2019Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
390000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
33054000
CY2019Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
2768000
CY2019Q4 omer Long Term Purchase Commitment Termination Fee
LongTermPurchaseCommitmentTerminationFee
22700000
CY2019Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
16848648
CY2019Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4400000
CY2019Q4 us-gaap Share Price
SharePrice
13.10
CY2019Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
54200000
CY2017Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3000000.0
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11713000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12688000
CY2017Q3 us-gaap Share Price
SharePrice
22.75
CY2017Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
63600000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
16900000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5400000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13785000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10313138
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.22
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2098705
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.23
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
799815
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.50
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
404097
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
16.28
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11207931
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.72
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
31912000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
10876043
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
11.65
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
31661000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
8212177
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.87
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y1M6D
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
29546000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-11261000
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1668000
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-12929000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12929000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12900000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
126794000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
113928000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
40654000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
35739000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
9959000
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
2037000
CY2019Q4 omer Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
7908000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
14555000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
10413000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
199870000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
171086000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
8969000
CY2019Q4 omer Deferred Tax Liabilities Equity Component Of Convertible Debt
DeferredTaxLiabilitiesEquityComponentOfConvertibleDebt
11082000
CY2018Q4 omer Deferred Tax Liabilities Equity Component Of Convertible Debt
DeferredTaxLiabilitiesEquityComponentOfConvertibleDebt
12706000
CY2019Q4 omer Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
6480000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
17562000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
12706000
CY2019Q4 omer Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
182308000
CY2018Q4 omer Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
158380000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
182308000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
158380000
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2019 omer Deferred Tax Assets Valuation Allowance Percentage
DeferredTaxAssetsValuationAllowancePercentage
1
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
23900000
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
26400000
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.02
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.02
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.02
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-1.15
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.28
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.19
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.60
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.06
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.05
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.11
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.01
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.08
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.09
CY2019 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.040
CY2019 omer Defined Contribution Plan Maximum Employer Matching Contribution
DefinedContributionPlanMaximumEmployerMatchingContribution
4000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21779000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26753000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29856000
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33417000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
41018000
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
36091000
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
40957000
CY2019Q4 us-gaap Costs And Expenses
CostsAndExpenses
57121000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-19239000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9338000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11101000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-23704000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-24345000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-14453000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-16463000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-29225000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.50
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.58
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1588000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1655000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4608000
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22017000
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
29277000
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
32272000
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
40050000
CY2018Q4 us-gaap Costs And Expenses
CostsAndExpenses
40491000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-27689000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-30617000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-35442000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-18474000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-30054000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-33696000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-39472000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-23534000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.62
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.70
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.81
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48

Files In Submission

Name View Source Status
0001558370-20-001891-index-headers.html Edgar Link pending
0001558370-20-001891-index.html Edgar Link pending
0001558370-20-001891.txt Edgar Link pending
0001558370-20-001891-xbrl.zip Edgar Link pending
ex-10d20.htm Edgar Link pending
ex-23d1.htm Edgar Link pending
ex-31d1.htm Edgar Link pending
ex-31d2.htm Edgar Link pending
ex-32d1.htm Edgar Link pending
ex-32d2.htm Edgar Link pending
ex-4d1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
omer-20191231.xsd Edgar Link pending
omer-20191231x10k21f5b6.htm Edgar Link pending
omer-20191231x10k21f5b6006.jpg Edgar Link pending
omer-20191231x10k21f5b6008.jpg Edgar Link pending
omer-20191231x10k21f5b6_htm.xml Edgar Link completed
omer-20191231_cal.xml Edgar Link unprocessable
omer-20191231_def.xml Edgar Link unprocessable
omer-20191231_lab.xml Edgar Link unprocessable
omer-20191231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending